TriCo Bancshares — MarketDX

United States

TCBK▲

TriCo Bancshares declares $0.36 quarterly dividend

TriCo Bancshares declared a quarterly cash dividend of $0.36 per share, in line with its previous payout. The dividend is payable on September 25 to shareholders of record on September 11, with the ex-dividend date also set for September 11. Based on the current share price, the forward yield is 2.61%.

TCBK ▲

TCBK · Capital · Positive Declares $0.36 quarterly dividend, maintaining payout and providing income to shareholders.

Read original ↗

Seeking Alpha·44dRead more →

TCBK

Brodsky & Smith investigates boards of MarketAxess, CBIZ, Sanara MedTech, and TriCo Bancshares over merger deals

Brodsky & Smith is investigating the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares for potential breaches of fiduciary duty in connection with their respective merger agreements. The investigations concern whether the boards failed to conduct a fair process and whether the proposed transactions pay fair value to shareholders. MarketAxess is being acquired by Intercontinental Exchange for $167 per share in cash, representing an equity value of approximately $6.0 billion. CBIZ is being acquired by Grant Thornton Advisors for $55.00 per share in an all-cash deal with an enterprise value of $5 billion. Sanara MedTech is being acquired by MiMedx Group in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. TriCo Bancshares is being acquired by First Hawaiian in an all-stock deal where TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share, representing $63.12 per share based on First Hawaiian's closing price on July 10, 2026.

CBZ MKTX SMTI TCBK

CBZ · Regulation · Neutral Investigation into board's fiduciary duty in merger deal, outcome uncertain.

MKTX · Regulation · Neutral Investigation into board's fiduciary duty in merger deal, outcome uncertain.

SMTI · Regulation · Neutral Investigation into board's fiduciary duty in merger deal, outcome uncertain.

TCBK · Regulation · Neutral Investigation into board's fiduciary duty in merger deal, outcome uncertain.

Read original ↗

GlobeNewswire·61dRead more →

TCBK▼

Ademi LLP investigates TriCo Bancshares deal with First Hawaiian over fairness to public shareholders

Ademi LLP is investigating TriCo Bancshares for possible breaches of fiduciary duty in its recently announced transaction with First Hawaiian. TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share, representing $63.12 per share based on First Hawaiian's closing stock price on July 10, 2026. Upon closing, First Hawaiian shareholders are expected to own approximately 65% of the combined company, with TriCo shareholders holding the remaining 35%. The investigation focuses on whether the TriCo board is fulfilling its fiduciary duties, noting that TriCo insiders will receive substantial benefits as part of change of control arrangements and that the transaction agreement imposes a significant penalty if TriCo accepts a competing bid.

TCBK ▼FHB

TCBK · Capital · Negative Investigation into possible breaches of fiduciary duty by TriCo board, with insiders receiving benefits and a significant penalty for competing bids, raising concerns about shareholder fairness.

FHB · Capital · Neutral First Hawaiian is the acquirer; the investigation targets TriCo's board, not First Hawaiian, but the deal structure and potential litigation could affect the transaction.

Read original ↗

GlobeNewswire·75dRead more →

TCBK

Halper Sadeh LLC Investigates Fairness of TCBK, ESI, CRNX, SOLS Deals

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of TriCo Bancshares, Element Solutions, Crinetics Pharmaceuticals, and Solstice Advanced Materials are obtaining fair deals for their shareholders. The firm is examining TriCo Bancshares' sale to First Hawaiian for 2.095 First Hawaiian shares per TriCo share, with TriCo shareholders expected to own approximately 35% of the combined company. It is also reviewing Element Solutions' sale to Solstice Advanced Materials for $10.00 in cash and 0.500 shares of Solstice common stock per Element share, leaving Element shareholders with about 44% of the combined company. Additionally, the investigation covers Crinetics Pharmaceuticals' sale to Vertex Pharmaceuticals for $85.00 per share in cash, and Solstice Advanced Materials' merger with Element Solutions. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.

CRNX ESI SOLS TCBK VRTX

CRNX · Capital · Neutral Investigation into fairness of Crinetics' sale to Vertex; may seek increased consideration or additional disclosures.

ESI · Capital · Neutral Investigation into fairness of Element Solutions' sale to Solstice; may seek increased consideration or additional disclosures.

SOLS · Capital · Neutral Investigation into fairness of Solstice's merger with Element Solutions; may seek increased consideration or additional disclosures.

TCBK · Capital · Neutral Investigation into fairness of TriCo Bancshares' sale to First Hawaiian; may seek increased consideration or additional disclosures.

VRTX · Capital · Neutral Vertex is the buyer in Crinetics deal; investigation may affect deal terms or closing.

Read original ↗

GlobeNewswire·80dRead more →

TCBK

Brodsky & Smith Investigating Four Mergers for Potential Fiduciary Breaches

Brodsky & Smith announced investigations into the proposed acquisitions of TriCo Bancshares, Twin Vee PowerCats, Crinetics Pharmaceuticals, and Element Solutions. TriCo Bancshares is being acquired by First Hawaiian in an all-stock deal valued at $63.12 per share, while Twin Vee PowerCats will be acquired by USFM Corporation with shareholders receiving contingent value rights and shares in the combined public company. Crinetics Pharmaceuticals is being bought by Vertex Pharmaceuticals for $85.00 per share in cash, totaling approximately $10.0 billion, and Element Solutions is being acquired by Solstice Advanced Materials in a cash-and-stock transaction implying about $50.10 per share. Each investigation focuses on whether the respective board breached fiduciary duties by failing to conduct a fair process and secure fair value for shareholders.

CRNX ESI TCBK VEEE

CRNX · Regulation · Neutral Investigation into fiduciary breach during acquisition by Vertex; outcome uncertain.

ESI · Regulation · Neutral Investigation into fiduciary breach during acquisition by Solstice; outcome uncertain.

TCBK · Regulation · Neutral Investigation into fiduciary breach during acquisition by First Hawaiian; outcome uncertain.

VEEE · Regulation · Neutral Investigation into fiduciary breach during acquisition by USFM; outcome uncertain.

Read original ↗

GlobeNewswire·82dRead more →

TCBK▲6

First Hawaiian to acquire TriCo Bancshares in $2b all-stock deal

First Hawaiian has agreed to acquire TriCo Bancshares in an all-stock transaction valued at about US$2b. TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share. The deal follows strong momentum for TriCo, with a 43.90% one-year total shareholder return. TriCo closed at $60.07, trading at a price-to-earnings ratio of 14.9x, above the US Banks industry average of 12.2x but below a peer group average of 28.3x. A discounted cash flow model estimates fair value at $77.87 per share, suggesting the stock is undervalued.

FHB ▲TCBK ▲

FHB · Capital · Positive First Hawaiian is the acquirer in a $2B all-stock deal, which is a capital event (M&A).

TCBK · Capital · Positive TriCo Bancshares is being acquired at a premium, with shareholders receiving 2.095 First Hawaiian shares per TriCo share.

Read original ↗

Simply Wall St·82dRead more →